2020
Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health study
Podoltsev NA, Wang X, Wang R, Hofmann JN, Liao LM, Zeidan AM, Mesa R, Ma X. Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health study. International Journal Of Cancer 2020, 147: 948-957. PMID: 31904114, PMCID: PMC8919268, DOI: 10.1002/ijc.32853.Peer-Reviewed Original ResearchConceptsNIH-AARP DietPolycythemia veraMyeloproliferative neoplasmsEssential thrombocythemiaHazard ratioLifestyle factorsCaffeine intakeHealth StudyMultivariable Cox proportional hazards regression modelsCox proportional hazards regression modelRisk of PVProportional hazards regression modelsRisk of MPNLarge prospective studiesHazards regression modelsConfidence intervalsPhiladelphia chromosome-negative myeloproliferative neoplasmsMPN riskOverall cohortProspective cohortProspective studyInverse associationRisk factorsPV riskProtective effect
2019
Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International Consortium
Panagopoulou P, Skalkidou A, Marcotte E, Erdmann F, Ma X, Heck JE, Auvinen A, Mueller BA, Spector LG, Roman E, Metayer C, Magnani C, Pombo-de-Oliveira MS, Scheurer ME, Mora AM, Dockerty JD, Hansen J, Kang AY, Wang R, Doody DR, Kane E, Schüz J, Christodoulakis C, Ntzani E, Petridou ET, group F, group N. Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International Consortium. Cancer Epidemiology 2019, 59: 158-165. PMID: 30776582, PMCID: PMC7098424, DOI: 10.1016/j.canep.2019.01.022.Peer-Reviewed Original ResearchConceptsChildhood Leukemia International ConsortiumAcute myeloid leukemiaAML riskOdds ratioMyeloid leukemiaParental ageChildhood acute myeloid leukemiaPaternal age groupsInfants of mothersConfidence intervalsAdvanced maternal ageMultiple logistic regressionPooled-effect estimatesInfant acute myeloid leukemiaMaternal smokingMultiple gestationsMaternal ageChildhood cancerAML casesAge groupsLogistic regressionStudy designAge incrementsOlder childrenAge
2017
Survivorship Care Preferences: A Pilot Study of Young Adults With Cancer
Viola A, Mitchell HR, Salner A, Gillan E, Rotatori J, Cartmel B, Santacroce S, Ma X, Kadan-Lottick N. Survivorship Care Preferences: A Pilot Study of Young Adults With Cancer. Clinical Journal Of Oncology Nursing 2017, 21: e71-e78. PMID: 29658261, DOI: 10.1188/17.cjon.e71-e78.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCancer SurvivorsConnecticutFemaleHumansLeukemiaLymphomaMalePatient PreferencePilot ProjectsSarcomaSurveys and QuestionnairesYoung AdultConceptsSurvivorship researchYoung adultsSurvivorship care plansMonths of diagnosisHealthcare team membersLate complicationsSurvivorship careConnecticut hospitalsCare plansCare preferencesSurvivorship studiesHealth concernPilot studyAYAsDiagnosisCancer therapyMonthsAdultsNovel strategyParticipantsComplicationsPatientsSarcomaLymphomaHospitalThe Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment
Viola A, Balsamo L, Neglia JP, Brouwers P, Ma X, Kadan-Lottick NS. The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment. Journal Of Pediatric Hematology/Oncology 2017, 39: 174-178. PMID: 28085741, PMCID: PMC5364064, DOI: 10.1097/mph.0000000000000761.Peer-Reviewed Original ResearchConceptsLeukemia survivorsNeurocognitive impairmentAttention-deficit/hyperactivity disorder (ADHD) outcomesPediatric acute lymphoblastic leukemia survivorsPediatric acute lymphoblastic leukemia treatmentAcute lymphoblastic leukemia survivorsAcute lymphoblastic leukemia treatmentPotential late effectsAcute lymphoblastic leukemiaMultivariate logistic regressionExecutive Function Parent FormCross-sectional studyOngoing clinical careBehavior Rating InventoryComprehensive neuropsychological assessmentElevated scoresFirst remissionClinical outcomesLymphoblastic leukemiaLate effectsClinical careRating InventoryLeukemia treatmentCognitive impairmentIndex score
2016
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey
Mesa RA, Miller CB, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Paranagama DC, Dubinski DG, Naim A, Parasuraman S, Boyle J, Mascarenhas JO. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. Cancer 2016, 123: 449-458. PMID: 27690182, PMCID: PMC5297986, DOI: 10.1002/cncr.30325.Peer-Reviewed Original ResearchConceptsPatient respondentsPhysician respondentsTreatment goalsPhysicians' self-reported practicesProportion of patientsImportant treatment goalSatisfaction of patientsPatient-physician communicationPrognostic risk classificationSelf-reported practicesThrombotic eventsCommon symptomsSymptom improvementPatient recollectionSymptom assessmentPatients' perceptionsPatient educationDelay progressionImportant symptomPatientsRisk classificationSymptomsDisease managementLandmark surveyOne-third
2012
Methyl bromide exposure and cancer risk in the Agricultural Health Study
Barry KH, Koutros S, Lubin JH, Coble JB, Barone-Adesi F, Beane Freeman LE, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC. Methyl bromide exposure and cancer risk in the Agricultural Health Study. Cancer Causes & Control 2012, 23: 807-818. PMID: 22527160, PMCID: PMC3430844, DOI: 10.1007/s10552-012-9949-2.Peer-Reviewed Original ResearchConceptsStomach cancer riskMethyl bromide exposureCancer riskProstate cancerFamily historySignificant exposure-dependent increaseNonsignificant elevated riskRate ratioAgricultural Health StudyConfidence intervalsExposure-dependent increaseResultsA totalCommon cancerLifetime daysElevated riskHealth StudyPoisson regressionIntensity scoresCancerHuman carcinogenicityPesticide applicatorsHealth effectsStatistical significanceConclusionsOur resultsHuman health effects
2009
Diet, Lifestyle, and Acute Myeloid Leukemia in the NIH–AARP Cohort
Ma X, Park Y, Mayne ST, Wang R, Sinha R, Hollenbeck AR, Schatzkin A, Cross AJ. Diet, Lifestyle, and Acute Myeloid Leukemia in the NIH–AARP Cohort. American Journal Of Epidemiology 2009, 171: 312-322. PMID: 20042434, PMCID: PMC2842202, DOI: 10.1093/aje/kwp371.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaPack/dayMyeloid leukemiaHazard ratioMeat intakeNIH-AARP DietLarge prospective studiesMultivariate Cox modelHigh meat intakeMeat cooking methodsNIH-AARP cohortCurrent smokersFormer smokersIncident casesProspective studyUS cohortVegetable intakeDoneness levelRisk factorsHigh riskCox modelHealth StudyLeukemiaSmokersConfidence intervalsEnergy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
Sue LY, Schairer C, Ma X, Williams C, Chang SC, Miller AB, McCarty CA, Willcox BJ, Ziegler RG. Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort. Cancer Epidemiology Biomarkers & Prevention 2009, 18: 2842-2850. PMID: 19843674, PMCID: PMC2783562, DOI: 10.1158/1055-9965.epi-09-0087.Peer-Reviewed Original ResearchMeSH KeywordsAgedBreast NeoplasmsCohort StudiesDiet SurveysEnergy IntakeFemaleHumansMiddle AgedPostmenopausePrognosisRisk FactorsSurveys and QuestionnairesConceptsFood frequency questionnaireOvarian Cancer Screening Trial (PLCO) cohortPostmenopausal breast cancerBreast cancerEnergy intakeTrial cohortDietary assessmentIncident breast cancerBody mass indexBreast cancer riskFirst food frequency questionnaireLower energy intakeModest positive associationMultivariate RRsFrequency questionnaireHighest quartileMass indexLowest quartilePhysical activitySimilar riskCancer riskHuman studiesAge 55CancerAnimal experimentsIntake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Ferrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, Ma X, Mayne ST, Sinha R. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. British Journal Of Cancer 2009, 101: 178-184. PMID: 19513076, PMCID: PMC2713710, DOI: 10.1038/sj.bjc.6605118.Peer-Reviewed Original ResearchConceptsOvarian Cancer Screening TrialCancer Screening TrialBreast cancerDietary ironMeat mutagensHazard ratioScreening TrialSubsequent breast cancer riskCox proportional hazards regressionInvasive breast cancer casesRed meatFood frequency questionnaireInvasive breast cancerQuintiles of intakeProportional hazards regressionHaem iron intakeIntake of meatBreast cancer riskConfidence intervalsBreast cancer casesHeterocyclic aminesFrequency questionnaireHazards regressionProspective studyIron intakeObesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US Cohort
Ma X, Lim U, Park Y, Mayne ST, Wang R, Hartge P, Hollenbeck AR, Schatzkin A. Obesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US Cohort. American Journal Of Epidemiology 2009, 169: 1492-1499. PMID: 19395696, PMCID: PMC2727203, DOI: 10.1093/aje/kwp074.Peer-Reviewed Original ResearchConceptsRisk of MDSMyelodysplastic syndromeLifestyle factorsPhysical activityUS prospective studiesHealth-AARP DietLarge US cohortModifiable risk factorsBody mass indexRelation of obesityCurrent smokersFormer smokersMass indexSignificant positive associationAlcohol intakeCigarette smokingProspective studyProspective InvestigationUS cohortVegetable intakeRisk factorsMeat intakeHealth StudyAlcohol consumptionSmokers